Finally some good news with this stock. Curious how the earning will relate to the upcoming conference, if at all. You still in this Sano?
Chart looks a bit toppy, but at least there is a product up for approval. Curious, what the second product mentioned in the last conference will be this year. At least there is potential for upside to go along with the NOLs and solid financials. Cautiously optimistic about this year.